This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Clinical trial NCT07121946 · RECRUITING

Trial details

NCT number: NCT07121946
Sponsor: LTZ Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma Refractory/ Relapsed DLBCL - Diffuse Large B Cell Lymphoma Mantle Cell Lymphoma (MCL)Follicular Lymphoma ( FL)Marginal Zone Lymphoma (MZL)

Start date: 2026-01-29
Primary completion: 2028-02-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.